Golden Biotechnology Corporation (TPEX:4132)

Golden Biotechnology Revenue

Golden Biotechnology had revenue of 26.62M TWD in the half year ending June 30, 2025, a decrease of -7.87%. This brings the company's revenue in the last twelve months to 44.58M, down -22.46% year-over-year. In the year 2024, Golden Biotechnology had annual revenue of 40.92M, down -35.49%.

• Revenue (ttm): 44.58M
• Revenue Growth: -22.46%
• P/S Ratio: 15.47
• Revenue / Employee: 365.43K
• Employees: 122
• Market Cap: 689.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.92M	-22.51M	-35.49%
Dec 31, 2023	63.43M	-154.40M	-70.88%
Dec 31, 2022	217.83M	136.06M	166.39%
Dec 31, 2021	81.77M	-7.06M	-7.94%
Dec 31, 2020	88.83M	5.53M	6.64%